A growing body of randomized trials shows some routine procedures deliver little more than time and good bedside care would. With 2027 renewals the steepest in decades, that evidence belongs in the renewal conversation
A growing body of randomized trials shows some routine procedures deliver little more than time and good bedside care would.
With 2027 renewals the steepest in decades, that evidence belongs in the renewal conversation
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
A growing body of randomized trials shows some routine procedures deliver little more than time and good bedside care would. With 2027 renewals the steepest in decades, that evidence belongs in the renewal conversation
Open the app view to save this story, compare related coverage, and continue from the same source.